Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Matias-Guiu

Showing results (31-40 of 312) with videos related to

Pageof 32
Sort By:
The American Journal of Pathology|April 17, 2010
A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesisNúria Eritja, David Llobet, Mónica Domingo, et al.
Virchows Archiv : an International Journal of Pathology|December 17, 2024
The role of the pathologist in the design and conducting of biomarker-driven clinical trials in cancer: position paper of the European Society of PathologyXavier Matias-Guiu, Maria Rosaria Raspollini, Janina Kulka, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 5, 2023
Perceptions of Controversies and Unresolved Issues in the 2014 FIGO Staging System for Endometrial Cancer: Survey Results From Members of the International Society of Gynecological Pathologists and International Gynecologic Cancer SocietyNeslihan Kayraklioglu, Levon Katsakhyan, Paul A Cohen, et al.
Cancer Letters|February 18, 2014
MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcomaFrancesca Micci, Ludmila Gorunova, Sonia Gatius, et al.
Cancers|January 11, 2024
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A ReviewManel Albertí-Valls, Cristina Megino-Luque, Anna Macià, et al.
Human Pathology|July 16, 2005
Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosisJulie A Irving, Lluis Catasús, Alberto Gallardo, et al.
Critical Reviews in Oncology/Hematology|December 4, 2025
HER2 in gynecological malignancies: Bridging the gap between standardized pathological assessment and precision therapyGian Franco Zannoni, Angela Santoro, Giuseppe Angelico, et al.
Human Pathology|September 2, 2018
Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosisGeorgia Karpathiou, Xavier Matias-Guiu, Mousa Mobarki, et al.
Endocrine Pathology|October 8, 2013
Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomasEsmeralda Castelblanco, Maria Santacana, Joan Valls, et al.
Respirology (Carlton, Vic.)|April 16, 2015
TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusionsJosé M Porcel, Rosa Palma, Silvia Bielsa, et al.
Pageof 32

Showing results (31-40 of 312) with videos related to

Sort By:
Pageof 32
The American Journal of Pathology|April 17, 2010
A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesisNúria Eritja, David Llobet, Mónica Domingo, et al.
Virchows Archiv : an International Journal of Pathology|December 17, 2024
The role of the pathologist in the design and conducting of biomarker-driven clinical trials in cancer: position paper of the European Society of PathologyXavier Matias-Guiu, Maria Rosaria Raspollini, Janina Kulka, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 5, 2023
Perceptions of Controversies and Unresolved Issues in the 2014 FIGO Staging System for Endometrial Cancer: Survey Results From Members of the International Society of Gynecological Pathologists and International Gynecologic Cancer SocietyNeslihan Kayraklioglu, Levon Katsakhyan, Paul A Cohen, et al.
Cancer Letters|February 18, 2014
MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcomaFrancesca Micci, Ludmila Gorunova, Sonia Gatius, et al.
Cancers|January 11, 2024
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A ReviewManel Albertí-Valls, Cristina Megino-Luque, Anna Macià, et al.
Human Pathology|July 16, 2005
Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosisJulie A Irving, Lluis Catasús, Alberto Gallardo, et al.
Critical Reviews in Oncology/Hematology|December 4, 2025
HER2 in gynecological malignancies: Bridging the gap between standardized pathological assessment and precision therapyGian Franco Zannoni, Angela Santoro, Giuseppe Angelico, et al.
Human Pathology|September 2, 2018
Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosisGeorgia Karpathiou, Xavier Matias-Guiu, Mousa Mobarki, et al.
Endocrine Pathology|October 8, 2013
Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomasEsmeralda Castelblanco, Maria Santacana, Joan Valls, et al.
Respirology (Carlton, Vic.)|April 16, 2015
TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusionsJosé M Porcel, Rosa Palma, Silvia Bielsa, et al.
Pageof 32